Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1729 - 1736 of 11617 results
MintzRx — Summer 2022 Enforcement Round-Up: Key Trends in Pharmacy Enforcement Actions
October 3, 2022| Blog| Viewpoint
MintzRx — OCR Provides Post-Dobbs Guidance on Non-Discrimination to Pharmacies
October 3, 2022| Blog| Viewpoint
MintzRx — The 340B Drama Continues
October 3, 2022| Blog| Viewpoint
MintzRx — Medicaid Best Price Value Based Purchasing Rules Took Effect July 1, 2022
October 3, 2022| Blog| Viewpoint
MintzRx — Pressure to Combat High Drug Prices Lands PBMs in the Hot Seat
October 3, 2022| Blog| Viewpoint
MintzRx — Drug Pricing Update: The Inflation Reduction Act
October 3, 2022| Blog| Viewpoint
MintzRx Newsletter — Your Prescription for the Pharmaceutical Supply Chain
October 3, 2022| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.